APO Research

APO RESEARCH · REPORT

Pediatric Lower Limb Exoskeleton

Selected research

Market Outlook & Growth Opportunities

Global Pediatric Lower Limb Exoskeleton Market Outlook and Growth Opportunities 2026

Market perspective

The global Pediatric Lower Limb Exoskeleton market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pediatric Lower Limb Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pediatric Lower Limb Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pediatric Lower Limb Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pediatric Lower Limb Exoskeleton market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pediatric Lower Limb Exoskeleton market include Milebot, Hangzhou Taixi Intelligent Technology, Hangzhou Chengtian Technology, Parker Hannifin, Panasonic, Myomo, Marsi Bionics, LockHeed Martin and Lifeward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pediatric Lower Limb Exoskeleton market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pediatric Lower Limb Exoskeleton and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pediatric Lower Limb Exoskeleton sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pediatric Lower Limb Exoskeleton market size, projected growth trends, production technologies, key applications, and end-use industries.

Pediatric Lower Limb Exoskeleton Segment by Company

Milebot

Hangzhou Taixi Intelligent Technology

Hangzhou Chengtian Technology

Parker Hannifin

Panasonic

Myomo

Marsi Bionics

LockHeed Martin

Lifeward

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Bionik Laboratories

Alter G

Pediatric Lower Limb Exoskeleton Segment by Type

Power Type

Mechanical Type

Pediatric Lower Limb Exoskeleton Segment by Application

Rehabilitation Center

Family

Other

Pediatric Lower Limb Exoskeleton Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pediatric Lower Limb Exoskeleton status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pediatric Lower Limb Exoskeleton market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pediatric Lower Limb Exoskeleton significant trends, drivers, influence factors in global and regions.

6. To analyze Pediatric Lower Limb Exoskeleton competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Lower Limb Exoskeleton market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Lower Limb Exoskeleton and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Lower Limb Exoskeleton.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pediatric Lower Limb Exoskeleton market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pediatric Lower Limb Exoskeleton industry.

Chapter 3: Detailed analysis of Pediatric Lower Limb Exoskeleton manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pediatric Lower Limb Exoskeleton in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pediatric Lower Limb Exoskeleton in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pediatric Lower Limb Exoskeleton Industry Trends Table 2. Pediatric Lower Limb Exoskeleton Industry Drivers Table 3. Pediatric Lower Limb Exoskeleton Industry Opportunities and Challenges Table 4. Pediatric Lower Limb Exoskeleton Industry Restraints Table 5. Global Pediatric Lower Limb Exoskeleton Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pediatric Lower Limb Exoskeleton Revenue Share by Company (2021-2026) Table 7. Global Pediatric Lower Limb Exoskeleton Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Company (2021-2026) Table 9. Global Pediatric Lower Limb Exoskeleton Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Pediatric Lower Limb Exoskeleton Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pediatric Lower Limb Exoskeleton Key Company Manufacturing Base & Headquarters Table 12. Global Pediatric Lower Limb Exoskeleton Company, Product Type & Application Table 13. Global Pediatric Lower Limb Exoskeleton Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pediatric Lower Limb Exoskeleton by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Power Type Table 18. Significant Companies of Mechanical Type Table 19. Global Pediatric Lower Limb Exoskeleton Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Pediatric Lower Limb Exoskeleton Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Pediatric Lower Limb Exoskeleton Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Type (2021-2026) Table 23. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Type (2027-2032) Table 24. Global Pediatric Lower Limb Exoskeleton Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pediatric Lower Limb Exoskeleton Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pediatric Lower Limb Exoskeleton Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Type (2021-2026) Table 28. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Rehabilitation Center Table 30. Significant Companies of Family Table 31. Significant Companies of Other Table 32. Global Pediatric Lower Limb Exoskeleton Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pediatric Lower Limb Exoskeleton Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Pediatric Lower Limb Exoskeleton Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Application (2021-2026) Table 36. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Application (2027-2032) Table 37. Global Pediatric Lower Limb Exoskeleton Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pediatric Lower Limb Exoskeleton Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pediatric Lower Limb Exoskeleton Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Application (2021-2026) Table 41. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Application (2027-2032) Table 42. Global Pediatric Lower Limb Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pediatric Lower Limb Exoskeleton Sales by Region (2021-2026) & (K Units) Table 44. Global Pediatric Lower Limb Exoskeleton Sales Market Share by Region (2021-2026) Table 45. Global Pediatric Lower Limb Exoskeleton Sales by Region (2027-2032) & (K Units) Table 46. Global Pediatric Lower Limb Exoskeleton Sales Market Share by Region (2027-2032) Table 47. Global Pediatric Lower Limb Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pediatric Lower Limb Exoskeleton Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Region (2021-2026) Table 50. Global Pediatric Lower Limb Exoskeleton Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Region (2027-2032) Table 52. Global Pediatric Lower Limb Exoskeleton Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Pediatric Lower Limb Exoskeleton Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Pediatric Lower Limb Exoskeleton Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Pediatric Lower Limb Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pediatric Lower Limb Exoskeleton Sales by Country (2021-2026) & (K Units) Table 57. Global Pediatric Lower Limb Exoskeleton Sales Market Share by Country (2021-2026) Table 58. Global Pediatric Lower Limb Exoskeleton Sales by Country (2027-2032) & (K Units) Table 59. Global Pediatric Lower Limb Exoskeleton Sales Market Share by Country (2027-2032) Table 60. Global Pediatric Lower Limb Exoskeleton Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pediatric Lower Limb Exoskeleton Sales Value Market Share by Country (2021-2026) Table 62. Global Pediatric Lower Limb Exoskeleton Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pediatric Lower Limb Exoskeleton Sales Value Market Share by Country (2027-2032) Table 64. Milebot Company Information Table 65. Milebot Business Overview Table 66. Milebot Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Milebot Pediatric Lower Limb Exoskeleton Product Portfolio Table 68. Milebot Recent Development Table 69. Hangzhou Taixi Intelligent Technology Company Information Table 70. Hangzhou Taixi Intelligent Technology Business Overview Table 71. Hangzhou Taixi Intelligent Technology Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Hangzhou Taixi Intelligent Technology Pediatric Lower Limb Exoskeleton Product Portfolio Table 73. Hangzhou Taixi Intelligent Technology Recent Development Table 74. Hangzhou Chengtian Technology Company Information Table 75. Hangzhou Chengtian Technology Business Overview Table 76. Hangzhou Chengtian Technology Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hangzhou Chengtian Technology Pediatric Lower Limb Exoskeleton Product Portfolio Table 78. Hangzhou Chengtian Technology Recent Development Table 79. Parker Hannifin Company Information Table 80. Parker Hannifin Business Overview Table 81. Parker Hannifin Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Parker Hannifin Pediatric Lower Limb Exoskeleton Product Portfolio Table 83. Parker Hannifin Recent Development Table 84. Panasonic Company Information Table 85. Panasonic Business Overview Table 86. Panasonic Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Panasonic Pediatric Lower Limb Exoskeleton Product Portfolio Table 88. Panasonic Recent Development Table 89. Myomo Company Information Table 90. Myomo Business Overview Table 91. Myomo Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Myomo Pediatric Lower Limb Exoskeleton Product Portfolio Table 93. Myomo Recent Development Table 94. Marsi Bionics Company Information Table 95. Marsi Bionics Business Overview Table 96. Marsi Bionics Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Marsi Bionics Pediatric Lower Limb Exoskeleton Product Portfolio Table 98. Marsi Bionics Recent Development Table 99. LockHeed Martin Company Information Table 100. LockHeed Martin Business Overview Table 101. LockHeed Martin Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. LockHeed Martin Pediatric Lower Limb Exoskeleton Product Portfolio Table 103. LockHeed Martin Recent Development Table 104. Lifeward Company Information Table 105. Lifeward Business Overview Table 106. Lifeward Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lifeward Pediatric Lower Limb Exoskeleton Product Portfolio Table 108. Lifeward Recent Development Table 109. Hocoma Company Information Table 110. Hocoma Business Overview Table 111. Hocoma Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hocoma Pediatric Lower Limb Exoskeleton Product Portfolio Table 113. Hocoma Recent Development Table 114. Ekso Bionics Company Information Table 115. Ekso Bionics Business Overview Table 116. Ekso Bionics Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Ekso Bionics Pediatric Lower Limb Exoskeleton Product Portfolio Table 118. Ekso Bionics Recent Development Table 119. Cyberdyne Company Information Table 120. Cyberdyne Business Overview Table 121. Cyberdyne Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Cyberdyne Pediatric Lower Limb Exoskeleton Product Portfolio Table 123. Cyberdyne Recent Development Table 124. B-TEMIA Inc. Company Information Table 125. B-TEMIA Inc. Business Overview Table 126. B-TEMIA Inc. Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. B-TEMIA Inc. Pediatric Lower Limb Exoskeleton Product Portfolio Table 128. B-TEMIA Inc. Recent Development Table 129. Bionik Laboratories Company Information Table 130. Bionik Laboratories Business Overview Table 131. Bionik Laboratories Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Bionik Laboratories Pediatric Lower Limb Exoskeleton Product Portfolio Table 133. Bionik Laboratories Recent Development Table 134. Alter G Company Information Table 135. Alter G Business Overview Table 136. Alter G Pediatric Lower Limb Exoskeleton Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Alter G Pediatric Lower Limb Exoskeleton Product Portfolio Table 138. Alter G Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Pediatric Lower Limb Exoskeleton Distributors List Table 142. Pediatric Lower Limb Exoskeleton Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pediatric Lower Limb Exoskeleton Product Image Figure 2. Global Pediatric Lower Limb Exoskeleton Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pediatric Lower Limb Exoskeleton Sales (2021-2032) & (K Units) Figure 5. Global Pediatric Lower Limb Exoskeleton Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Pediatric Lower Limb Exoskeleton Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Power Type Image Figure 10. Mechanical Type Image Figure 11. Global Pediatric Lower Limb Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Pediatric Lower Limb Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Type (2021-2032) Figure 14. Global Pediatric Lower Limb Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pediatric Lower Limb Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Type (2021-2032) Figure 17. Rehabilitation Center Image Figure 18. Family Image Figure 19. Other Image Figure 20. Global Pediatric Lower Limb Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pediatric Lower Limb Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Application (2021-2032) Figure 23. Global Pediatric Lower Limb Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pediatric Lower Limb Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Application (2021-2032) Figure 26. Global Pediatric Lower Limb Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Pediatric Lower Limb Exoskeleton Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pediatric Lower Limb Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pediatric Lower Limb Exoskeleton Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pediatric Lower Limb Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pediatric Lower Limb Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pediatric Lower Limb Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pediatric Lower Limb Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pediatric Lower Limb Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pediatric Lower Limb Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pediatric Lower Limb Exoskeleton Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pediatric Lower Limb Exoskeleton Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Power Type
  • Mechanical Type
Applications
  • Rehabilitation Center
  • Family
  • Other
Companies covered
  • Milebot
  • Hangzhou Taixi Intelligent Technology
  • Hangzhou Chengtian Technology
  • Parker Hannifin
  • Panasonic
  • Myomo
  • Marsi Bionics
  • LockHeed Martin
  • Lifeward
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Bionik Laboratories
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  4. 1.2.2 Global Pediatric Lower Limb Exoskeleton Sales Volume (2021-2032)
  5. 1.2.3 Global Pediatric Lower Limb Exoskeleton Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pediatric Lower Limb Exoskeleton Market Dynamics
  1. 2.1 Pediatric Lower Limb Exoskeleton Industry Trends
  2. 2.2 Pediatric Lower Limb Exoskeleton Industry Drivers
  3. 2.3 Pediatric Lower Limb Exoskeleton Industry Opportunities and Challenges
  4. 2.4 Pediatric Lower Limb Exoskeleton Industry Restraints
3 Pediatric Lower Limb Exoskeleton Market by Company
  1. 3.1 Global Pediatric Lower Limb Exoskeleton Company Revenue Ranking in 2025
  2. 3.2 Global Pediatric Lower Limb Exoskeleton Revenue by Company (2021-2026)
  3. 3.3 Global Pediatric Lower Limb Exoskeleton Sales Volume by Company (2021-2026)
  4. 3.4 Global Pediatric Lower Limb Exoskeleton Average Price by Company (2021-2026)
  5. 3.5 Global Pediatric Lower Limb Exoskeleton Company Ranking (2024-2026)
  6. 3.6 Global Pediatric Lower Limb Exoskeleton Company Manufacturing Base and Headquarters
  7. 3.7 Global Pediatric Lower Limb Exoskeleton Company Product Type and Application
  8. 3.8 Global Pediatric Lower Limb Exoskeleton Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pediatric Lower Limb Exoskeleton Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pediatric Lower Limb Exoskeleton Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pediatric Lower Limb Exoskeleton Market by Type
  1. 4.1 Pediatric Lower Limb Exoskeleton Type Introduction
  2. 4.1.1 Power Type
  3. 4.1.2 Mechanical Type
  4. 4.2 Global Pediatric Lower Limb Exoskeleton Sales Volume by Type
  5. 4.2.1 Global Pediatric Lower Limb Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pediatric Lower Limb Exoskeleton Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pediatric Lower Limb Exoskeleton Sales Value by Type
  9. 4.3.1 Global Pediatric Lower Limb Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pediatric Lower Limb Exoskeleton Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pediatric Lower Limb Exoskeleton Sales Value Share by Type (2021-2032)
5 Pediatric Lower Limb Exoskeleton Market by Application
  1. 5.1 Pediatric Lower Limb Exoskeleton Application Introduction
  2. 5.1.1 Rehabilitation Center
  3. 5.1.2 Family
  4. 5.1.3 Other
  5. 5.2 Global Pediatric Lower Limb Exoskeleton Sales Volume by Application
  6. 5.2.1 Global Pediatric Lower Limb Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pediatric Lower Limb Exoskeleton Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pediatric Lower Limb Exoskeleton Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pediatric Lower Limb Exoskeleton Sales Value by Application
  10. 5.3.1 Global Pediatric Lower Limb Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pediatric Lower Limb Exoskeleton Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pediatric Lower Limb Exoskeleton Sales Value Share by Application (2021-2032)
6 Pediatric Lower Limb Exoskeleton Regional Sales and Value Analysis
  1. 6.1 Global Pediatric Lower Limb Exoskeleton Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pediatric Lower Limb Exoskeleton Sales by Region (2021-2032)
  3. 6.2.1 Global Pediatric Lower Limb Exoskeleton Sales by Region: 2021-2026
  4. 6.2.2 Global Pediatric Lower Limb Exoskeleton Sales by Region (2027-2032)
  5. 6.3 Global Pediatric Lower Limb Exoskeleton Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pediatric Lower Limb Exoskeleton Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pediatric Lower Limb Exoskeleton Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pediatric Lower Limb Exoskeleton Sales Value by Region (2027-2032)
  9. 6.5 Global Pediatric Lower Limb Exoskeleton Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  12. 6.6.2 North America Pediatric Lower Limb Exoskeleton Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  15. 6.7.2 Europe Pediatric Lower Limb Exoskeleton Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pediatric Lower Limb Exoskeleton Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  21. 6.9.2 South America Pediatric Lower Limb Exoskeleton Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pediatric Lower Limb Exoskeleton Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pediatric Lower Limb Exoskeleton Sales Value Share by Country, 2025 VS 2032
7 Pediatric Lower Limb Exoskeleton Country-level Sales and Value Analysis
  1. 7.1 Global Pediatric Lower Limb Exoskeleton Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pediatric Lower Limb Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pediatric Lower Limb Exoskeleton Sales by Country (2021-2032)
  4. 7.3.1 Global Pediatric Lower Limb Exoskeleton Sales by Country (2021-2026)
  5. 7.3.2 Global Pediatric Lower Limb Exoskeleton Sales by Country (2027-2032)
  6. 7.4 Global Pediatric Lower Limb Exoskeleton Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pediatric Lower Limb Exoskeleton Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pediatric Lower Limb Exoskeleton Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pediatric Lower Limb Exoskeleton Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pediatric Lower Limb Exoskeleton Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pediatric Lower Limb Exoskeleton Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Milebot
  2. 8.1.1 Milebot Company Information
  3. 8.1.2 Milebot Business Overview
  4. 8.1.3 Milebot Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Milebot Pediatric Lower Limb Exoskeleton Product Portfolio
  6. 8.1.5 Milebot Recent Developments
  7. 8.2 Hangzhou Taixi Intelligent Technology
  8. 8.2.1 Hangzhou Taixi Intelligent Technology Company Information
  9. 8.2.2 Hangzhou Taixi Intelligent Technology Business Overview
  10. 8.2.3 Hangzhou Taixi Intelligent Technology Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hangzhou Taixi Intelligent Technology Pediatric Lower Limb Exoskeleton Product Portfolio
  12. 8.2.5 Hangzhou Taixi Intelligent Technology Recent Developments
  13. 8.3 Hangzhou Chengtian Technology
  14. 8.3.1 Hangzhou Chengtian Technology Company Information
  15. 8.3.2 Hangzhou Chengtian Technology Business Overview
  16. 8.3.3 Hangzhou Chengtian Technology Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Chengtian Technology Pediatric Lower Limb Exoskeleton Product Portfolio
  18. 8.3.5 Hangzhou Chengtian Technology Recent Developments
  19. 8.4 Parker Hannifin
  20. 8.4.1 Parker Hannifin Company Information
  21. 8.4.2 Parker Hannifin Business Overview
  22. 8.4.3 Parker Hannifin Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Parker Hannifin Pediatric Lower Limb Exoskeleton Product Portfolio
  24. 8.4.5 Parker Hannifin Recent Developments
  25. 8.5 Panasonic
  26. 8.5.1 Panasonic Company Information
  27. 8.5.2 Panasonic Business Overview
  28. 8.5.3 Panasonic Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Panasonic Pediatric Lower Limb Exoskeleton Product Portfolio
  30. 8.5.5 Panasonic Recent Developments
  31. 8.6 Myomo
  32. 8.6.1 Myomo Company Information
  33. 8.6.2 Myomo Business Overview
  34. 8.6.3 Myomo Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Myomo Pediatric Lower Limb Exoskeleton Product Portfolio
  36. 8.6.5 Myomo Recent Developments
  37. 8.7 Marsi Bionics
  38. 8.7.1 Marsi Bionics Company Information
  39. 8.7.2 Marsi Bionics Business Overview
  40. 8.7.3 Marsi Bionics Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Marsi Bionics Pediatric Lower Limb Exoskeleton Product Portfolio
  42. 8.7.5 Marsi Bionics Recent Developments
  43. 8.8 LockHeed Martin
  44. 8.8.1 LockHeed Martin Company Information
  45. 8.8.2 LockHeed Martin Business Overview
  46. 8.8.3 LockHeed Martin Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LockHeed Martin Pediatric Lower Limb Exoskeleton Product Portfolio
  48. 8.8.5 LockHeed Martin Recent Developments
  49. 8.9 Lifeward
  50. 8.9.1 Lifeward Company Information
  51. 8.9.2 Lifeward Business Overview
  52. 8.9.3 Lifeward Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lifeward Pediatric Lower Limb Exoskeleton Product Portfolio
  54. 8.9.5 Lifeward Recent Developments
  55. 8.10 Hocoma
  56. 8.10.1 Hocoma Company Information
  57. 8.10.2 Hocoma Business Overview
  58. 8.10.3 Hocoma Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hocoma Pediatric Lower Limb Exoskeleton Product Portfolio
  60. 8.10.5 Hocoma Recent Developments
  61. 8.11 Ekso Bionics
  62. 8.11.1 Ekso Bionics Company Information
  63. 8.11.2 Ekso Bionics Business Overview
  64. 8.11.3 Ekso Bionics Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ekso Bionics Pediatric Lower Limb Exoskeleton Product Portfolio
  66. 8.11.5 Ekso Bionics Recent Developments
  67. 8.12 Cyberdyne
  68. 8.12.1 Cyberdyne Company Information
  69. 8.12.2 Cyberdyne Business Overview
  70. 8.12.3 Cyberdyne Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cyberdyne Pediatric Lower Limb Exoskeleton Product Portfolio
  72. 8.12.5 Cyberdyne Recent Developments
  73. 8.13 B-TEMIA Inc.
  74. 8.13.1 B-TEMIA Inc. Company Information
  75. 8.13.2 B-TEMIA Inc. Business Overview
  76. 8.13.3 B-TEMIA Inc. Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B-TEMIA Inc. Pediatric Lower Limb Exoskeleton Product Portfolio
  78. 8.13.5 B-TEMIA Inc. Recent Developments
  79. 8.14 Bionik Laboratories
  80. 8.14.1 Bionik Laboratories Company Information
  81. 8.14.2 Bionik Laboratories Business Overview
  82. 8.14.3 Bionik Laboratories Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bionik Laboratories Pediatric Lower Limb Exoskeleton Product Portfolio
  84. 8.14.5 Bionik Laboratories Recent Developments
  85. 8.15 Alter G
  86. 8.15.1 Alter G Company Information
  87. 8.15.2 Alter G Business Overview
  88. 8.15.3 Alter G Pediatric Lower Limb Exoskeleton Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Alter G Pediatric Lower Limb Exoskeleton Product Portfolio
  90. 8.15.5 Alter G Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pediatric Lower Limb Exoskeleton Value Chain Analysis
  2. 9.1.1 Pediatric Lower Limb Exoskeleton Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pediatric Lower Limb Exoskeleton Sales Mode & Process
  6. 9.2 Pediatric Lower Limb Exoskeleton Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pediatric Lower Limb Exoskeleton Distributors
  9. 9.2.3 Pediatric Lower Limb Exoskeleton Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research